Evaluation of the Role of Nigerian Pharmacists in Promoting Lifestyle Modification in Prevention and Control of Hypertension
Rashidat O. Ayanniyi1*, Muslim O.Jamiu2, Medina Kola-Olaniyan1
1 Department of Pharmacology and Toxicology, Faculty of Pharmaceutical Sciences, University of Ilorin, Nigeria.
2 Department of Clinical Pharmacy and Pharmacy administration, Faculty of Pharmaceutical Sciences, University of Ilorin, Nigeria.
*Corresponding author: Dr. Rashidat O. Ayanniyi. E-mail: email@example.com (08033908610).
Background: Hypertension is one of the most prevalent non-communicable conditions worldwide and currently a global medical and public health issue. A public health approach to the prevention and control of hypertension needs to be adopted, one that promotes healthy dietary habits, a tobacco-free lifestyle, regular physical activity and a supportive psychosocial environment. Pharmacists and other health care professionals will play a vital role in the promotion and success of this approach, because they interact on a regular basis with a large proportion of the population and are well placed to counsel individual patients. The objective of this study was to document the role of Nigerian pharmacists in promoting lifestyle modification in the prevention and control hypertension.
Methods: A descriptive cross sectional study conducted during the Annual National Conference of Pharmaceutical Society of Nigeria (2013) in Ilorin, Kwara State, Nigeria. Data was collected using semi-structured questionnaires administered to 370 Community and Hospital Pharmacists. Descriptive data was presented in the form of frequency and percentages. Statistical analysis was carried out using Chi square test and a p value of < 0.05 was considered statistically significant.
Results: Three hundred and fifty questionnaires were completed giving a response rate of 94.6%. The respondents (60.3 %) performed blood pressure screening and monitoring in their practice setting while 52.9 % educate and counsel patients on life style modification. There was a significant association between Pharmacist’s educational qualifications and the provision of blood pressure screening and monitoring services (P=0.000) but none with patients education about life style modification (P=0.272). The Pharmacist’s area of practice was found to be significantly associated with the provision of patients education and counseling (P=0.000).
Conclusion: Nigerian Pharmacists educate and counsel their patients on healthy dietary habits, dietary salt restriction, healthy body weight, regular physical activity and reduction in alcohol consumption. They also provide blood pressure screening and monitoring services to their patients.
Keywords: Hypertension, pharmacist, counseling, education, healthy lifestyle
TO DOWNLOAD THE FULL TEXT: CLICK HERE
- Madhur MS, Lob HE, McCann LA, Iwakura Y, Blinder Y, Guzik TJ, Harrison DG (2010). Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction. Hypertension55(2):500-507.
- Addo J, Smeeth L, Leon DA (2007). Hypertension in Sub-Saharan Africa, a systemic review. Hypertension50 (6):1012-1018.
- Ekwunife OI, Aguwa CN (2011). A meta analysis of prevalence rate of hypertension in Nigerian populations. Journal of Public Health and Epidemiology 3 (13): 604-607.
- World Health Organization. World Health Statistics 2012. Retrieved December, 2012 from http://www.who.int/healthinfo/EN_WHS2012_. Accessed September 2014
- Ganiyu KA, Suleiman IA (2014). Economic Burden of Drug Therapy in Hypertension Management in a Private Teaching Hospital in Nigeria. British Journal of Pharmaceutical Research 4(1):70-78.
- Pierdomenico SD, DiNicola M, Esposito AL, DiMascio, Ballone E, Lapenna D (2009) Prognostic value of different indices of blood pressure variability in hypertensive patients. American Journal of Hypertension 22(8):842-847.
- Campbell NRC, Burgess E, Choi BCK, Taylor G, Wilson E, Cléroux J (1999). Lifestyle modifications to prevent and control hypertension: 1. Methods and an overview of the Canadian recommendations. Canadian Medical Association Journal160 (9 Suppl): S1-6.
- CarreteroOA, Oparil S (2000). Essential hypertension Part I: definition and etiology. Circulation 101(3):329-335.
- Rule AD, Fridley BL, Hunt SC, Asmann Y, Boerwinkle E, PankowJS (2009). Genome-wide linkage analysis for uric acid in families enriched for hypertension. Nephrology Dialysis Transplantation 24(8): 2414-2420.
- Wofford MR, Hall JE (2004). Pathophysiology and treatment of obesity hypertension. Current Pharmaceutical Design 10 (29):3621-3637.
- Kyrou I, Chrousos GP, Tsigos C (2006). Stress, visceral obesity, and metabolic complications. Annals of the New York Academy of Sciences 1083:77-110.
- Wu G, Tian H, Han K, Xi Y, Yao Y, Ma A (2006). Potassium magnesium supplementation for four weeks improves small distal artery compliance and reduces blood pressure in patients with essential hypertension. Clinical andExperimental Hypertension28(5):489-497.
- Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL (2003). Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. Hypertension 42(6):1206-1252.
- Wells BG, DiPiro JT, Schwinghammer TL, Hamilton W (2006). Hypertension. In: Pharmacotherapy Handbook 6th Edition McGraw-Hill.
- WHO (2005) “Preventing Chronic Diseases: A Vital Investment.” http://www.who.int/chp/chronic_disease_report/contents/foreword.pdfAccessed September 2014.
- Joseph JS, Barry LS (2005). Hypertension In: Pharmacotherapy: A Pathophysiologic Approach 6th Edition, McGraw-Hill.
- Murphy JE, Nappi JM, Bosso JA (2006) American College of Clinical Pharmacy’s vision of the future: postgraduate pharmacy residency training as a prerequisite for direct patient care practice. Pharmacotherapy 26: 722-733.
- Robert-Jan M and Bas K (2010) Digital forensic sampling: The application of statistical sampling in digital forensics: URL: https://blogs.sans.org/computer-forensics/files/2010/03/statisticalforensictriage.pdf Accessed February 2014.
- Adje DU, Oli AN. Community Pharmacy in Warri, Nigeria-A Survey of Practice Details. Acad. J. Pharm 2013;2(5): 391-397.
- American Pharmaceutical Association. Pharmacist Practice Activity Classification (2006). http://www.aphanet.org/AM/Template.cfm?Section=Search&template=/CM/HTMLDisplay.cfm&ContentID=2908. Accessed June 15, 2015.
- McDonough RP, Doucette WR. (2003). Drug therapy management: an empirical report of drug therapy problems, pharmacists’ interventions, and results of pharmacists’ actions. J Amer Pharm Assn 43:511-518.
- Oparah AC (2012). Models of pharmacy practice In: Essentials of pharmaceutical care 1st ed. Oparah AC(ed) All Deals Investment Company, Lagos pp1-20.
- Joffres MR, Hamet P, Rabkin SW, Gelskey D, Hogan K, Fodor G, Canadian (1992). Heart Health Surveys Research Group. Prevalence, control and awareness of high blood pressure amongst Canadian adults. Canadian Medical Association Journal 146(11):1997-2005.
- Oparah AC (2012). Pharmaceutical care in hypertension in: Essentials of Pharmaceutical care 1st edition, Oparah AC. All Deals investment limited pp 20-25.
- International Pharmaceutical Federation (2006). The Role of the Pharmacist in the Prevention and Treatment of Chronic Disease. https://www.fip.org/www/uploads/database_file.php?id=274&table_id=
- Wong FYY, Chan FWK, You JHS, Wong LY, YeohEK (2011) Patient self-management and pharmacist-led patient self-management in Hong Kong: A focus group study from different healthcare professionals’ perspectives. BMC Health Services Research11:121.